番茄社区app

News, features, and commentary about cancer-related issues

25 drugs chosen so far comprise about a third of Medicare Part D spending on prescription drugs

Radiation exposure, type and cumulative dose of chemotherapy drive melanoma risk

Incidence of cytokine release syndrome was minimal with the investigational therapy

Phase III data show promising efficacy with manageable toxicity and feasible delivery

Treatment tied to higher recovery odds and faster time to kidney recovery

FDA boxed warning led to multiple studies on the issue in 2024

News, features, and commentary about cancer-related issues

Studies show promising EFS, PFS, and OS at 3 to 8 years

Novel CD19xCD3 T-cell engager showed high response rate in phase I study

News, features, and commentary about cancer-related issues

Promising single-agent efficacy with manageable safety may reshape initial treatment

Experts talk about long-term data and the importance of infection prophylaxis

Alarming mental health challenges among young cancer survivors, especially males, demand action